Selected research
Market Outlook & Growth Opportunities
Global Gene Therapy Viral Packaging Service Market Outlook and Growth Opportunities 2026
Market perspective
The global Gene Therapy Viral Packaging Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Gene Therapy Viral Packaging Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Gene Therapy Viral Packaging Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Gene Therapy Viral Packaging Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Gene Therapy Viral Packaging Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Gene Therapy Viral Packaging Service market include GenScript, Abace Biology, Genecfps, GENEWIZ, Obio Technology, Charles River Laboratories, Takara Bio, abm and Cell Biolabs, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Gene Therapy Viral Packaging Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Gene Therapy Viral Packaging Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Gene Therapy Viral Packaging Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Gene Therapy Viral Packaging Service market.
Gene Therapy Viral Packaging Service Segment by Company
GenScript
Abace Biology
Genecfps
GENEWIZ
Obio Technology
Charles River Laboratories
Takara Bio
abm
Cell Biolabs
Cyagen
Vector Biolabs
Lonza
Oxford BioMedica
Catalent
Wuxi Shengji Pharmaceuticals
Boten Biotech
Cytiva
Packgene
VectorBuilder
Ubigene
Gene Therapy Viral Packaging Service Segment by Type
Adeno-Associated Virus Packaging
Lentiviral Packaging
Adenovirus Packaging
Other
Gene Therapy Viral Packaging Service Segment by Application
Gene Therapy
Scientific Research
Gene Therapy Viral Packaging Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Gene Therapy Viral Packaging Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Gene Therapy Viral Packaging Service key companies, revenue, market share, and recent developments.
3. To split the Gene Therapy Viral Packaging Service breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Gene Therapy Viral Packaging Service market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Gene Therapy Viral Packaging Service significant trends, drivers, influence factors in global and regions.
6. To analyze Gene Therapy Viral Packaging Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Therapy Viral Packaging Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gene Therapy Viral Packaging Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Therapy Viral Packaging Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gene Therapy Viral Packaging Service industry.
Chapter 3: Detailed analysis of Gene Therapy Viral Packaging Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Gene Therapy Viral Packaging Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Gene Therapy Viral Packaging Service in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
List of Tables
Table 1. Gene Therapy Viral Packaging Service Industry Trends
Table 2. Gene Therapy Viral Packaging Service Industry Drivers
Table 3. Gene Therapy Viral Packaging Service Industry Opportunities and Challenges
Table 4. Gene Therapy Viral Packaging Service Industry Restraints
Table 5. Global Gene Therapy Viral Packaging Service Revenue by Company (US$ Million) & (2021-2026)
Table 6. Global Gene Therapy Viral Packaging Service Revenue Share by Company (2021-2026)
Table 7. Global Gene Therapy Viral Packaging Service Company Ranking, (2024-2026) & (US$ Million)
Table 8. Global Gene Therapy Viral Packaging Service Key Company Manufacturing Base & Headquarters
Table 9. Global Gene Therapy Viral Packaging Service Company, Product Type & Application
Table 10. Global Gene Therapy Viral Packaging Service Company Establishment Date
Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
Table 12. Global Gene Therapy Viral Packaging Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025)
Table 13. Mergers & Acquisitions, Expansion
Table 14. Significant Companies of Adeno-Associated Virus Packaging
Table 15. Significant Companies of Lentiviral Packaging
Table 16. Significant Companies of Adenovirus Packaging
Table 17. Significant Companies of Other
Table 18. Global Gene Therapy Viral Packaging Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 19. Global Gene Therapy Viral Packaging Service Sales Value by Type (2021-2026) & (US$ Million)
Table 20. Global Gene Therapy Viral Packaging Service Sales Value by Type (2027-2032) & (US$ Million)
Table 21. Global Gene Therapy Viral Packaging Service Sales Value Share by Type (2021-2026)
Table 22. Global Gene Therapy Viral Packaging Service Sales Value Share by Type (2027-2032)
Table 23. Significant Companies of Gene Therapy
Table 24. Significant Companies of Scientific Research
Table 25. Global Gene Therapy Viral Packaging Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 26. Global Gene Therapy Viral Packaging Service Sales Value by Application (2021-2026) & (US$ Million)
Table 27. Global Gene Therapy Viral Packaging Service Sales Value by Application (2027-2032) & (US$ Million)
Table 28. Global Gene Therapy Viral Packaging Service Sales Value Share by Application (2021-2026)
Table 29. Global Gene Therapy Viral Packaging Service Sales Value Share by Application (2027-2032)
Table 30. Global Gene Therapy Viral Packaging Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 31. Global Gene Therapy Viral Packaging Service Sales Value by Region (2021-2026) & (US$ Million)
Table 32. Global Gene Therapy Viral Packaging Service Sales Value Share by Region (2021-2026)
Table 33. Global Gene Therapy Viral Packaging Service Sales Value by Region (2027-2032) & (US$ Million)
Table 34. Global Gene Therapy Viral Packaging Service Sales Value Share by Region (2027-2032)
Table 35. Global Gene Therapy Viral Packaging Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 36. Global Gene Therapy Viral Packaging Service Sales Value by Country (2021-2026) & (US$ Million)
Table 37. Global Gene Therapy Viral Packaging Service Sales Value Market Share by Country (2021-2026)
Table 38. Global Gene Therapy Viral Packaging Service Sales Value by Country (2027-2032) & (US$ Million)
Table 39. Global Gene Therapy Viral Packaging Service Sales Value Market Share by Country (2027-2032)
Table 40. GenScript Company Information
Table 41. GenScript Business Overview
Table 42. GenScript Gene Therapy Viral Packaging Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 43. GenScript Gene Therapy Viral Packaging Service Product Portfolio
Table 44. GenScript Recent Development
Table 45. Abace Biology Company Information
Table 46. Abace Biology Business Overview
Table 47. Abace Biology Gene Therapy Viral Packaging Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 48. Abace Biology Gene Therapy Viral Packaging Service Product Portfolio
Table 49. Abace Biology Recent Development
Table 50. Genecfps Company Information
Table 51. Genecfps Business Overview
Table 52. Genecfps Gene Therapy Viral Packaging Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 53. Genecfps Gene Therapy Viral Packaging Service Product Portfolio
Table 54. Genecfps Recent Development
Table 55. GENEWIZ Company Information
Table 56. GENEWIZ Business Overview
Table 57. GENEWIZ Gene Therapy Viral Packaging Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 58. GENEWIZ Gene Therapy Viral Packaging Service Product Portfolio
Table 59. GENEWIZ Recent Development
Table 60. Obio Technology Company Information
Table 61. Obio Technology Business Overview
Table 62. Obio Technology Gene Therapy Viral Packaging Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 63. Obio Technology Gene Therapy Viral Packaging Service Product Portfolio
Table 64. Obio Technology Recent Development
Table 65. Charles River Laboratories Company Information
Table 66. Charles River Laboratories Business Overview
Table 67. Charles River Laboratories Gene Therapy Viral Packaging Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 68. Charles River Laboratories Gene Therapy Viral Packaging Service Product Portfolio
Table 69. Charles River Laboratories Recent Development
Table 70. Takara Bio Company Information
Table 71. Takara Bio Business Overview
Table 72. Takara Bio Gene Therapy Viral Packaging Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 73. Takara Bio Gene Therapy Viral Packaging Service Product Portfolio
Table 74. Takara Bio Recent Development
Table 75. abm Company Information
Table 76. abm Business Overview
Table 77. abm Gene Therapy Viral Packaging Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 78. abm Gene Therapy Viral Packaging Service Product Portfolio
Table 79. abm Recent Development
Table 80. Cell Biolabs Company Information
Table 81. Cell Biolabs Business Overview
Table 82. Cell Biolabs Gene Therapy Viral Packaging Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 83. Cell Biolabs Gene Therapy Viral Packaging Service Product Portfolio
Table 84. Cell Biolabs Recent Development
Table 85. Cyagen Company Information
Table 86. Cyagen Business Overview
Table 87. Cyagen Gene Therapy Viral Packaging Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 88. Cyagen Gene Therapy Viral Packaging Service Product Portfolio
Table 89. Cyagen Recent Development
Table 90. Vector Biolabs Company Information
Table 91. Vector Biolabs Business Overview
Table 92. Vector Biolabs Gene Therapy Viral Packaging Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 93. Vector Biolabs Gene Therapy Viral Packaging Service Product Portfolio
Table 94. Vector Biolabs Recent Development
Table 95. Lonza Company Information
Table 96. Lonza Business Overview
Table 97. Lonza Gene Therapy Viral Packaging Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 98. Lonza Gene Therapy Viral Packaging Service Product Portfolio
Table 99. Lonza Recent Development
Table 100. Oxford BioMedica Company Information
Table 101. Oxford BioMedica Business Overview
Table 102. Oxford BioMedica Gene Therapy Viral Packaging Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 103. Oxford BioMedica Gene Therapy Viral Packaging Service Product Portfolio
Table 104. Oxford BioMedica Recent Development
Table 105. Catalent Company Information
Table 106. Catalent Business Overview
Table 107. Catalent Gene Therapy Viral Packaging Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 108. Catalent Gene Therapy Viral Packaging Service Product Portfolio
Table 109. Catalent Recent Development
Table 110. Wuxi Shengji Pharmaceuticals Company Information
Table 111. Wuxi Shengji Pharmaceuticals Business Overview
Table 112. Wuxi Shengji Pharmaceuticals Gene Therapy Viral Packaging Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 113. Wuxi Shengji Pharmaceuticals Gene Therapy Viral Packaging Service Product Portfolio
Table 114. Wuxi Shengji Pharmaceuticals Recent Development
Table 115. Boten Biotech Company Information
Table 116. Boten Biotech Business Overview
Table 117. Boten Biotech Gene Therapy Viral Packaging Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 118. Boten Biotech Gene Therapy Viral Packaging Service Product Portfolio
Table 119. Boten Biotech Recent Development
Table 120. Cytiva Company Information
Table 121. Cytiva Business Overview
Table 122. Cytiva Gene Therapy Viral Packaging Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 123. Cytiva Gene Therapy Viral Packaging Service Product Portfolio
Table 124. Cytiva Recent Development
Table 125. Packgene Company Information
Table 126. Packgene Business Overview
Table 127. Packgene Gene Therapy Viral Packaging Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 128. Packgene Gene Therapy Viral Packaging Service Product Portfolio
Table 129. Packgene Recent Development
Table 130. VectorBuilder Company Information
Table 131. VectorBuilder Business Overview
Table 132. VectorBuilder Gene Therapy Viral Packaging Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 133. VectorBuilder Gene Therapy Viral Packaging Service Product Portfolio
Table 134. VectorBuilder Recent Development
Table 135. Ubigene Company Information
Table 136. Ubigene Business Overview
Table 137. Ubigene Gene Therapy Viral Packaging Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 138. Ubigene Gene Therapy Viral Packaging Service Product Portfolio
Table 139. Ubigene Recent Development
Table 140. Research Programs/Design for This Report
Table 141. Authors List of This Report
Table 142. Secondary Sources
Table 143. Primary Sources
List of Figures
Figure 1. Gene Therapy Viral Packaging Service Product Image
Figure 2. Global Gene Therapy Viral Packaging Service Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Gene Therapy Viral Packaging Service Market Size (2021-2032) & (US$ Million)
Figure 4. Global Gene Therapy Viral Packaging Service Company Revenue Ranking in 2025 (US$ Million)
Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million)
Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 7. Adeno-Associated Virus Packaging Image
Figure 8. Lentiviral Packaging Image
Figure 9. Adenovirus Packaging Image
Figure 10. Other Image
Figure 11. Global Gene Therapy Viral Packaging Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 12. Global Gene Therapy Viral Packaging Service Sales Value Share 2021 VS 2025 VS 2032
Figure 13. Global Gene Therapy Viral Packaging Service Sales Value Share by Type (2021-2032)
Figure 14. Gene Therapy Image
Figure 15. Scientific Research Image
Figure 16. Global Gene Therapy Viral Packaging Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 17. Global Gene Therapy Viral Packaging Service Sales Value Share 2021 VS 2025 VS 2032
Figure 18. Global Gene Therapy Viral Packaging Service Sales Value Share by Application (2021-2032)
Figure 19. Global Gene Therapy Viral Packaging Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 20. Global Gene Therapy Viral Packaging Service Sales Value Share by Region: 2021 VS 2025 VS 2032
Figure 21. North America Gene Therapy Viral Packaging Service Sales Value (2021-2032) & (US$ Million)
Figure 22. North America Gene Therapy Viral Packaging Service Sales Value Share by Country (%), 2025 VS 2032
Figure 23. Europe Gene Therapy Viral Packaging Service Sales Value (2021-2032) & (US$ Million)
Figure 24. Europe Gene Therapy Viral Packaging Service Sales Value Share by Country (%), 2025 VS 2032
Figure 25. Asia-Pacific Gene Therapy Viral Packaging Service Sales Value (2021-2032) & (US$ Million)
Figure 26. Asia-Pacific Gene Therapy Viral Packaging Service Sales Value Share by Country (%), 2025 VS 2032
Figure 27. South America Gene Therapy Viral Packaging Service Sales Value (2021-2032) & (US$ Million)
Figure 28. South America Gene Therapy Viral Packaging Service Sales Value Share by Country (%), 2025 VS 2032
Figure 29. Middle East & Africa Gene Therapy Viral Packaging Service Sales Value (2021-2032) & (US$ Million)
Figure 30. Middle East & Africa Gene Therapy Viral Packaging Service Sales Value Share by Country (%), 2025 VS 2032
Figure 31. USA Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 32. USA Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 33. USA Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 34. Canada Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 35. Canada Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 36. Canada Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 37. Mexico Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 38. Mexico Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 39. Mexico Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 40. Germany Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 41. Germany Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 42. Germany Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 43. France Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 44. France Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 45. France Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 46. U.K. Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 47. U.K. Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 48. U.K. Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 49. Italy Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 50. Italy Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 51. Italy Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 52. Spain Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 53. Spain Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 54. Spain Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 55. Russia Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 56. Russia Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 57. Russia Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 58. Netherlands Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 59. Netherlands Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 60. Netherlands Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 61. Nordic Countries Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 62. Nordic Countries Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 63. Nordic Countries Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 64. China Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 65. China Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 66. China Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 67. Japan Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 68. Japan Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 69. Japan Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 70. South Korea Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 71. South Korea Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 72. South Korea Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 73. India Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 74. India Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 75. India Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 76. Australia Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 77. Australia Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 78. Australia Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 79. Southeast Asia Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 80. Southeast Asia Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 81. Southeast Asia Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 82. Brazil Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 83. Brazil Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 84. Brazil Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 85. Argentina Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 86. Argentina Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 87. Argentina Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 88. Chile Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 89. Chile Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 90. Chile Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 91. Colombia Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 92. Colombia Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 93. Colombia Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 94. Peru Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 95. Peru Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 96. Peru Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 97. Saudi Arabia Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 98. Saudi Arabia Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 99. Saudi Arabia Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 100. Israel Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 101. Israel Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 102. Israel Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 103. UAE Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 104. UAE Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 105. UAE Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 106. Turkey Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 107. Turkey Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 108. Turkey Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 109. Iran Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 110. Iran Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 111. Iran Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 112. Egypt Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 113. Egypt Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 114. Egypt Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 115. Years Considered
Figure 116. Research Process
Figure 117. Key Executives Interviewed
Scope & coverage.
Types
- Adeno-Associated Virus Packaging
- Lentiviral Packaging
- Adenovirus Packaging
- Other
Applications
- Gene Therapy
- Scientific Research
Companies covered
- GenScript
- Abace Biology
- Genecfps
- GENEWIZ
- Obio Technology
- Charles River Laboratories
- Takara Bio
- abm
- Cell Biolabs
- Cyagen
- Vector Biolabs
- Lonza
- Oxford BioMedica
- Catalent
- Wuxi Shengji Pharmaceuticals
- Boten Biotech
- Cytiva
- Packgene
- VectorBuilder
- Ubigene
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Gene Therapy Viral Packaging Service Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Gene Therapy Viral Packaging Service Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Gene Therapy Viral Packaging Service Market Dynamics
- 2.1 Gene Therapy Viral Packaging Service Industry Trends
- 2.2 Gene Therapy Viral Packaging Service Industry Drivers
- 2.3 Gene Therapy Viral Packaging Service Industry Opportunities and Challenges
- 2.4 Gene Therapy Viral Packaging Service Industry Restraints
3 Gene Therapy Viral Packaging Service Market by Company
- 3.1 Global Gene Therapy Viral Packaging Service Company Revenue Ranking in 2025
- 3.2 Global Gene Therapy Viral Packaging Service Revenue by Company (2021-2026)
- 3.3 Global Gene Therapy Viral Packaging Service Company Ranking (2024-2026)
- 3.4 Global Gene Therapy Viral Packaging Service Company Manufacturing Base and Headquarters
- 3.5 Global Gene Therapy Viral Packaging Service Company Product Type and Application
- 3.6 Global Gene Therapy Viral Packaging Service Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Gene Therapy Viral Packaging Service Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Gene Therapy Viral Packaging Service Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Gene Therapy Viral Packaging Service Market by Type
- 4.1 Gene Therapy Viral Packaging Service Type Introduction
- 4.1.1 Adeno-Associated Virus Packaging
- 4.1.2 Lentiviral Packaging
- 4.1.3 Adenovirus Packaging
- 4.1.4 Other
- 4.2 Global Gene Therapy Viral Packaging Service Sales Value by Type
- 4.2.1 Global Gene Therapy Viral Packaging Service Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Gene Therapy Viral Packaging Service Sales Value by Type (2021-2032)
- 4.2.3 Global Gene Therapy Viral Packaging Service Sales Value Share by Type (2021-2032)
5 Gene Therapy Viral Packaging Service Market by Application
- 5.1 Gene Therapy Viral Packaging Service Application Introduction
- 5.1.1 Gene Therapy
- 5.1.2 Scientific Research
- 5.2 Global Gene Therapy Viral Packaging Service Sales Value by Application
- 5.2.1 Global Gene Therapy Viral Packaging Service Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Gene Therapy Viral Packaging Service Sales Value by Application (2021-2032)
- 5.2.3 Global Gene Therapy Viral Packaging Service Sales Value Share by Application (2021-2032)
6 Gene Therapy Viral Packaging Service Regional Value Analysis
- 6.1 Global Gene Therapy Viral Packaging Service Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Gene Therapy Viral Packaging Service Sales Value by Region (2021-2032)
- 6.2.1 Global Gene Therapy Viral Packaging Service Sales Value by Region: 2021-2026
- 6.2.2 Global Gene Therapy Viral Packaging Service Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Gene Therapy Viral Packaging Service Sales Value (2021-2032)
- 6.3.2 North America Gene Therapy Viral Packaging Service Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Gene Therapy Viral Packaging Service Sales Value (2021-2032)
- 6.4.2 Europe Gene Therapy Viral Packaging Service Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Gene Therapy Viral Packaging Service Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Gene Therapy Viral Packaging Service Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Gene Therapy Viral Packaging Service Sales Value (2021-2032)
- 6.6.2 South America Gene Therapy Viral Packaging Service Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Gene Therapy Viral Packaging Service Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Gene Therapy Viral Packaging Service Sales Value Share by Country, 2025 VS 2032
7 Gene Therapy Viral Packaging Service Country-level Value Analysis
- 7.1 Global Gene Therapy Viral Packaging Service Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Gene Therapy Viral Packaging Service Sales Value by Country (2021-2032)
- 7.2.1 Global Gene Therapy Viral Packaging Service Sales Value by Country (2021-2026)
- 7.2.2 Global Gene Therapy Viral Packaging Service Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032)
- 7.7.2 France Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032)
- 7.14.2 China Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032)
- 7.17.2 India Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Gene Therapy Viral Packaging Service Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Gene Therapy Viral Packaging Service Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Gene Therapy Viral Packaging Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 GenScript
- 8.1.1 GenScript Company Information
- 8.1.2 GenScript Business Overview
- 8.1.3 GenScript Gene Therapy Viral Packaging Service Revenue and Gross Margin (2021-2026)
- 8.1.4 GenScript Gene Therapy Viral Packaging Service Product Portfolio
- 8.1.5 GenScript Recent Developments
- 8.2 Abace Biology
- 8.2.1 Abace Biology Company Information
- 8.2.2 Abace Biology Business Overview
- 8.2.3 Abace Biology Gene Therapy Viral Packaging Service Revenue and Gross Margin (2021-2026)
- 8.2.4 Abace Biology Gene Therapy Viral Packaging Service Product Portfolio
- 8.2.5 Abace Biology Recent Developments
- 8.3 Genecfps
- 8.3.1 Genecfps Company Information
- 8.3.2 Genecfps Business Overview
- 8.3.3 Genecfps Gene Therapy Viral Packaging Service Revenue and Gross Margin (2021-2026)
- 8.3.4 Genecfps Gene Therapy Viral Packaging Service Product Portfolio
- 8.3.5 Genecfps Recent Developments
- 8.4 GENEWIZ
- 8.4.1 GENEWIZ Company Information
- 8.4.2 GENEWIZ Business Overview
- 8.4.3 GENEWIZ Gene Therapy Viral Packaging Service Revenue and Gross Margin (2021-2026)
- 8.4.4 GENEWIZ Gene Therapy Viral Packaging Service Product Portfolio
- 8.4.5 GENEWIZ Recent Developments
- 8.5 Obio Technology
- 8.5.1 Obio Technology Company Information
- 8.5.2 Obio Technology Business Overview
- 8.5.3 Obio Technology Gene Therapy Viral Packaging Service Revenue and Gross Margin (2021-2026)
- 8.5.4 Obio Technology Gene Therapy Viral Packaging Service Product Portfolio
- 8.5.5 Obio Technology Recent Developments
- 8.6 Charles River Laboratories
- 8.6.1 Charles River Laboratories Company Information
- 8.6.2 Charles River Laboratories Business Overview
- 8.6.3 Charles River Laboratories Gene Therapy Viral Packaging Service Revenue and Gross Margin (2021-2026)
- 8.6.4 Charles River Laboratories Gene Therapy Viral Packaging Service Product Portfolio
- 8.6.5 Charles River Laboratories Recent Developments
- 8.7 Takara Bio
- 8.7.1 Takara Bio Company Information
- 8.7.2 Takara Bio Business Overview
- 8.7.3 Takara Bio Gene Therapy Viral Packaging Service Revenue and Gross Margin (2021-2026)
- 8.7.4 Takara Bio Gene Therapy Viral Packaging Service Product Portfolio
- 8.7.5 Takara Bio Recent Developments
- 8.8 abm
- 8.8.1 abm Company Information
- 8.8.2 abm Business Overview
- 8.8.3 abm Gene Therapy Viral Packaging Service Revenue and Gross Margin (2021-2026)
- 8.8.4 abm Gene Therapy Viral Packaging Service Product Portfolio
- 8.8.5 abm Recent Developments
- 8.9 Cell Biolabs
- 8.9.1 Cell Biolabs Company Information
- 8.9.2 Cell Biolabs Business Overview
- 8.9.3 Cell Biolabs Gene Therapy Viral Packaging Service Revenue and Gross Margin (2021-2026)
- 8.9.4 Cell Biolabs Gene Therapy Viral Packaging Service Product Portfolio
- 8.9.5 Cell Biolabs Recent Developments
- 8.10 Cyagen
- 8.10.1 Cyagen Company Information
- 8.10.2 Cyagen Business Overview
- 8.10.3 Cyagen Gene Therapy Viral Packaging Service Revenue and Gross Margin (2021-2026)
- 8.10.4 Cyagen Gene Therapy Viral Packaging Service Product Portfolio
- 8.10.5 Cyagen Recent Developments
- 8.11 Vector Biolabs
- 8.11.1 Vector Biolabs Company Information
- 8.11.2 Vector Biolabs Business Overview
- 8.11.3 Vector Biolabs Gene Therapy Viral Packaging Service Revenue and Gross Margin (2021-2026)
- 8.11.4 Vector Biolabs Gene Therapy Viral Packaging Service Product Portfolio
- 8.11.5 Vector Biolabs Recent Developments
- 8.12 Lonza
- 8.12.1 Lonza Company Information
- 8.12.2 Lonza Business Overview
- 8.12.3 Lonza Gene Therapy Viral Packaging Service Revenue and Gross Margin (2021-2026)
- 8.12.4 Lonza Gene Therapy Viral Packaging Service Product Portfolio
- 8.12.5 Lonza Recent Developments
- 8.13 Oxford BioMedica
- 8.13.1 Oxford BioMedica Company Information
- 8.13.2 Oxford BioMedica Business Overview
- 8.13.3 Oxford BioMedica Gene Therapy Viral Packaging Service Revenue and Gross Margin (2021-2026)
- 8.13.4 Oxford BioMedica Gene Therapy Viral Packaging Service Product Portfolio
- 8.13.5 Oxford BioMedica Recent Developments
- 8.14 Catalent
- 8.14.1 Catalent Company Information
- 8.14.2 Catalent Business Overview
- 8.14.3 Catalent Gene Therapy Viral Packaging Service Revenue and Gross Margin (2021-2026)
- 8.14.4 Catalent Gene Therapy Viral Packaging Service Product Portfolio
- 8.14.5 Catalent Recent Developments
- 8.15 Wuxi Shengji Pharmaceuticals
- 8.15.1 Wuxi Shengji Pharmaceuticals Company Information
- 8.15.2 Wuxi Shengji Pharmaceuticals Business Overview
- 8.15.3 Wuxi Shengji Pharmaceuticals Gene Therapy Viral Packaging Service Revenue and Gross Margin (2021-2026)
- 8.15.4 Wuxi Shengji Pharmaceuticals Gene Therapy Viral Packaging Service Product Portfolio
- 8.15.5 Wuxi Shengji Pharmaceuticals Recent Developments
- 8.16 Boten Biotech
- 8.16.1 Boten Biotech Company Information
- 8.16.2 Boten Biotech Business Overview
- 8.16.3 Boten Biotech Gene Therapy Viral Packaging Service Revenue and Gross Margin (2021-2026)
- 8.16.4 Boten Biotech Gene Therapy Viral Packaging Service Product Portfolio
- 8.16.5 Boten Biotech Recent Developments
- 8.17 Cytiva
- 8.17.1 Cytiva Company Information
- 8.17.2 Cytiva Business Overview
- 8.17.3 Cytiva Gene Therapy Viral Packaging Service Revenue and Gross Margin (2021-2026)
- 8.17.4 Cytiva Gene Therapy Viral Packaging Service Product Portfolio
- 8.17.5 Cytiva Recent Developments
- 8.18 Packgene
- 8.18.1 Packgene Company Information
- 8.18.2 Packgene Business Overview
- 8.18.3 Packgene Gene Therapy Viral Packaging Service Revenue and Gross Margin (2021-2026)
- 8.18.4 Packgene Gene Therapy Viral Packaging Service Product Portfolio
- 8.18.5 Packgene Recent Developments
- 8.19 VectorBuilder
- 8.19.1 VectorBuilder Company Information
- 8.19.2 VectorBuilder Business Overview
- 8.19.3 VectorBuilder Gene Therapy Viral Packaging Service Revenue and Gross Margin (2021-2026)
- 8.19.4 VectorBuilder Gene Therapy Viral Packaging Service Product Portfolio
- 8.19.5 VectorBuilder Recent Developments
- 8.20 Ubigene
- 8.20.1 Ubigene Company Information
- 8.20.2 Ubigene Business Overview
- 8.20.3 Ubigene Gene Therapy Viral Packaging Service Revenue and Gross Margin (2021-2026)
- 8.20.4 Ubigene Gene Therapy Viral Packaging Service Product Portfolio
- 8.20.5 Ubigene Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$4,250USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst